Best treatments for urinary bladder neoplasms

Understanding urinary bladder neoplasms

Bladder cancer is a cancer that begins in the cells lining the bladder, the organ that stores urine. According to the National Cancer Institute (NCI), the most common symptom is blood in the urine, called hematuria, which is often slightly rusty to bright red in color. Other symptoms can include frequent urination, pain or burning during urination, feeling as if you need to urinate even when the bladder isn't full, and urinating often during the night. NCI notes these symptoms can also be caused by non-cancerous conditions such as urinary tract infections or kidney or bladder stones, and advises checking with your doctor if you have any of them. To diagnose bladder cancer, NCI describes checking a urine sample in the lab for blood, abnormal cells, or infection; urine tumor marker tests; imaging such as a CT urogram; and cystoscopy, in which a lighted instrument is inserted through the urethra to view inside the bladder. A biopsy taken during cystoscopy is examined by a pathologist under a microscope to confirm cancer. Management depends on whether the cancer is non-muscle-invasive or muscle-invasive and on its stage. This is general information, not medical advice.

Frequently asked

What treats urinary bladder neoplasms?

Our catalog lists 17 products that may treat urinary bladder neoplasms, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is opdivo.

What is the best-rated treatment for urinary bladder neoplasms?

By our independent recall-safety rating — not an efficacy measure — opdivo ranks highest among the products we list for urinary bladder neoplasms. Always consult a professional.

How are these treatments ranked?

By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.

What types of drugs treat urinary bladder neoplasms?

Treatments for urinary bladder neoplasms span FDA drug classes including programmed death receptor-1 blocking antibody, interleukin-15 receptor agonist, topoisomerase inhibitor, platinum-based drug, anthracycline topoisomerase inhibitor. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.